bioRN News

OLS – OMNI Life Science accelerates cell research with smart, reliable, and user-friendly technologies for life sciences and biotechnology. Their products are used in public, private, pharmaceutical, and biotech labs. The portfolio includes instruments, media, reagents, consumables, and services for Cell Counting, Culture, Imaging, Flow Cytometry, and Analysis. OLS supports researchers throughout the entire process, […]

Daiichi Sankyo’s European roots date back to the 1980s with branches in Düsseldorf. In 1990, Sankyo acquired Luitpold-Werke, a German pharmaceutical company, expanding operations to Pfaffenhofen, Germany, and Altkirch, France. In 2006, Daiichi and Sankyo merged, with European headquarters in Munich. Now present in 13 countries, Daiichi Sankyo employs over 2,000 people, making it one […]

SPT Labtech transforms the way scientists work by pioneering automation in liquid handling, sample preparation, and management for over 25 years. Their solutions streamline lab tasks, reduce human error, and ensure precise, consistent results. Using positive displacement technology, they enable ultra-low volume accuracy, saving reagents and samples. Their automated systems simplify sample storage and organization, […]

YUMAB GmbH (“YUMAB”), a leading antibody discovery CRO headquartered in Braunschweig, Germany, and MOLCURE Inc. (“MOLCURE”), an AI-driven drug discovery company based in Kawasaki, Japan, announced their on-going collaboration now includes advancing the application of zero-shot AI technology for antibody discovery. The collaboration brings together complementary expertise and technologies. MOLCURE has a decade of experience […]

Bacteria that are sensitive to drugs can become resilient when part of communities, with the help of cross-protection strategies Summary Many human medications can directly inhibit the growth and alter the function of the bacteria that constitute our gut microbiome. EMBL Heidelberg researchers have now discovered that this effect is reduced when bacteria form communities. […]

Heidelberg researchers identify biological mechanism that protects against, but can also trigger, errors in the genome Certain developmental signals shape not only the human embryo but also play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. An international research team led by scientists of the Centre […]

Personalized medicine with individually tailored therapies is becoming more and more a reality in cancer. This requires a precise look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out […]

Heidelberg, Germany, 24.09.2024 – RHEACELL today announced that the U.S. Food and Drug Administration (FDA) approved the companies blinded, multi-centric Phase-3 trial (NCT06489028) to investigate allo-APZ2-CVU in patients with chronic venous ulcers (CVU). Allo-APZ2-CVU is a first-in-class stem cell therapy leveraging ABCB5-positive mesenchymal stem cells (MSCs) to treat patients with severe immune and inflammation-driven diseases […]

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and […]